Buyout bid made for Warner Chilcott

10/26/2004 | Wall Street Journal, The

Warner Chilcott, manufacturer of estrogen-replacement therapies and acne drugs, confirmed it has been approached by one of three financial outfits with apparent plans to buy the company, but would not identify the suitor. Since three are said to be interested, the idea of an auction for the company was developing, and a source said Goldman Sachs Capital Partners is the group that made the approach.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC